On January 16, the U.S. Drug Enforcement Administration (DEA) announced three new telemedicine rules that extend prescribing flexibilities ...

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

“A review of the comments persuaded DEA and HHS that the requirements … would be overly burdensome for the majority of patients,” the final rule stated. The rule notes that these new ...

Scholar argues for tele-prescription reforms that can increase patient access to necessary controlled substances.

DEA includes two additional requirements for schedule II substances. One is that the patient and provider must be located in the same state. Additionally, a provider with an advanced special ...

The DEA’s proposed 50/50 telehealth rule ... Instead of implementing arbitrary in-person requirements, we should focus on improving the standard of care through evidence-based practices.

Applications for one of the three tiers would occur on a three-year cycle using a new form, the DEA proposes. The agency also wants to institute requirements that prescriptions only be issued once ...

As that public health emergency wound down, DEA issued a proposal in February 2023 that removed those flexibilities and reinstated in-person requirements. After receiving industry criticism that ...

The DEA’s proposed 50/50 telehealth rule undermines the accessibility and effectiveness of psychiatric care by imposing unnecessary in-person visit requirements. Here's how.